Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. - Wikidata - wikimedia - TriplyDB

Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.

Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.

http://www.wikidata.org/entity/Q50335804

about

Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti Structural Basis for Recognition of Diubiquitins by NEMO Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways.Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms.Systematic review of central nervous system anomalies in incontinentia pigmenti.TRAF molecules in cell signaling and in human diseases The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.Role of non-degradative ubiquitination in interleukin-1 and toll-like receptor signaling.GSK-3β controls NF-kappaB activity via IKKγ/NEMO.Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.COMMD7 as a novel NEMO interacting protein involved in the termination of NF-κB signaling.Disulfide-mediated stabilization of the IκB kinase binding domain of NF-κB essential modulator (NEMO).Identification of tyrosine-9 of MAVS as critical target for inducible phosphorylation that determines activation.A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease.Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II.The LCR at the IKBKG locus is prone to recombine.Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations.Rhbdd3 controls autoimmunity by suppressing the production of IL-6 by dendritic cells via K27-linked ubiquitination of the regulator NEMO.TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling.Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.Ubiquitination of NEMO by TRAF6 Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy

P2860

Q24315943-A6878153-43CF-4773-8907-015F540334E3 Q27330416-FA506332-CA40-4EF0-A525-52599053D4B1 Q27653619-60E9F416-9080-469B-927E-AFB3DD2CF2E9 Q33588166-B69A4224-6155-484C-9B42-5D4490FECE3B Q34399689-80A7A041-4CE5-43E6-8422-9D63E6B3F286 Q34743768-A3F0955C-39B8-437D-A1F4-70ABB4E87F1B Q35913320-133059F7-7D82-491B-8CA3-29D48F383EE3 Q36621551-F5A268D4-CFCD-48E6-9791-CBBE1CCED123 Q36972287-08805268-A89D-4566-9AC1-83551144C89A Q36974840-8AD1738D-DCA0-4577-8A00-492537C47332 Q37036380-33076AAC-514B-4AEF-B87C-1F8D819B41C3 Q37233348-7050C345-B7D8-4BDC-B94B-8A5745BEB9E7 Q37236668-FA06F8DE-9F47-471A-A8E1-6AA6AF18BE3F Q37483862-3AB2FC16-2CDD-4DDA-8062-66D8EDAEB964 Q38070410-D01130FC-3931-4CCE-96AF-3A401B243D31 Q38171457-0A3F3793-6F46-42BA-A6E2-D91E845F2E42 Q38865492-DC4C2E1E-9C59-4B8F-A430-46A9EDA4B8FD Q38940206-999D4AB2-D408-408A-AE6C-097286694C06 Q39306129-35E19757-B137-4AA2-81B1-429BE6B0C2D4 Q39460310-D0A4C340-F747-4B87-A1C4-46A42E487E8C Q39696024-CB8455FB-AE27-4F3F-BF4A-AAC171D8081A Q42369047-15802062-9157-4081-A857-CE5FCDC67F42 Q42848390-585415E3-A0AE-4357-A58E-131586339C1D Q43785411-C2480637-9DA0-45D4-8566-AED2F16B63A0 Q45718626-7DBA8D5C-9259-4A9C-B32F-14A9467A4F66 Q47368912-9723B97D-D4BB-402F-8AFB-F794F959EF36 Q49634849-E9613DEA-1098-4096-A27F-ACC0BBF9AB91 Q50291420-C3AE8B4D-5E53-490F-9C2A-7A0D4996F142 Q58728912-3505891B-3B03-436D-9F0F-C3BC103C02A2

P2860

Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.

http://www.wikidata.org/entity/Q50335804

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@en

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@nl

type

label

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@en

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@nl

prefLabel

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@en

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@nl

P1433

Q50335804-BB99B87E-FBFC-4572-8629-3716DE0DAC09

P1476

Q50335804-03BE0302-99BC-435A-84AB-6E11A48A2AE7

P2093

Q50335804-17BA77A2-4F2A-48A4-BF78-916016B173F5

Q50335804-52B4D487-21AD-460C-9FB0-4F25C4D1BCB4

Q50335804-60C2D90A-8086-47E5-81B7-35C872EDE9A2

Q50335804-7BE59C42-BCAB-4C0B-97A8-0AF1F8D6B4A9

Q50335804-B1D5D0B4-8218-42EE-82D4-2F1A6BBA8CB6

Q50335804-B67ED8AF-478F-4E55-B562-65A63A9C63D8

Q50335804-B80752FF-BD66-48F0-A72A-F8896A754FC2

Q50335804-DD99AD9F-D017-46AC-933D-A32EA474E817

Q50335804-EBF7CFA5-CC46-4EA9-84BE-C7B94E016202

P2860

Q50335804-02A78F23-DE06-47E2-B9E5-E9BAE85144D9

Q50335804-0FC08BF0-AA92-4818-8F39-8D27425C661E

Q50335804-1797B01E-214C-45E7-9582-C1B841EA3A7C

Q50335804-2D95DF70-DC73-44B9-93B0-21985E892EED

Q50335804-41F14F41-011C-44E4-B079-D4F118C53413

Q50335804-482E0DDF-12A2-4A6A-AA14-030C1683F081

Q50335804-4FBD10E1-DE6F-49CF-A2FF-741E5101C9B8

Q50335804-55EBE09C-23D7-495B-BE66-D3E3A765531F

Q50335804-5C9915A6-9A48-4863-8BC1-A1C8F781BEDF

Q50335804-5F178DE6-89A3-4BA2-92AE-3193C416975E

P304

Q50335804-C3FF6018-20EC-4E86-B2F5-EE434CE41709

P31

Q50335804-672EE497-D804-4613-83D2-1FE115B6F923

P356

Q50335804-FB099D85-332C-481D-B519-6F4F5F729A38

P433

Q50335804-849A370B-50AA-4286-957F-07C73CF76952

P478

Q50335804-981FD984-2AAF-4C07-BAB0-A98CAE4BD2D2

P577

Q50335804-C17191A0-5007-47E5-B66D-B57075781EA2

P5875

Q50335804-0543ED41-BE50-4F94-A96B-9C58CF751A7A

P698

Q50335804-D9FBFE9F-F2FF-4647-97AF-0DFC763DF5E7

P921

Q50335804-762EB7CE-DDEA-4603-857F-AE8AB8F8E12D

P356

P1433

Human Molecular Genetics

P1476

Identification of TRAF6-depend ...... ausing incontinentia pigmenti.

@en

P2093

Alessandra Pescatore

http://www.w3.org/2001/XMLSchema#string

Anne Moncla

http://www.w3.org/2001/XMLSchema#string

Francesca Fusco

http://www.w3.org/2001/XMLSchema#string

Gilles Courtois

http://www.w3.org/2001/XMLSchema#string

Hélène Sebban-Benin

http://www.w3.org/2001/XMLSchema#string

Jérémie Gautheron

http://www.w3.org/2001/XMLSchema#string

Matilde Valeria Ursini

http://www.w3.org/2001/XMLSchema#string

Shoji Yamaoka

http://www.w3.org/2001/XMLSchema#string

Valérie Pascuale

http://www.w3.org/2001/XMLSchema#string

P2860

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO

RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase

The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)

Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium

P304

2805-2815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDM237

http://www.w3.org/2001/XMLSchema#string

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6112722

http://www.w3.org/2001/XMLSchema#string

P698

17728323

http://www.w3.org/2001/XMLSchema#string

P921